ArticleJournal for immunotherapy of cancer2020

Dual but not single PD-1 or TIM-3 blockade enhances oncolytic virotherapy in refractory lung cancer.

Fan Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.